Hepcinat

HEPCINAT seen as a genuine breakthrough in the treatment of chronic hepatitis C has recently emerged in the world pharmaceutical market.Sofosbuvir can now replace Interferon which is commonly known for causing certain adverse effects and having a number of contraindications. At the moment, it is already approved for use in the 120 countries worlwide. SOFOSBUVIR can be used for treatment of patients with cirrhosis and HIV.

Send Query